key: cord-0755389-6a7usdk6 authors: Camargo, Carlos Henrique; Gonçalves, Claudia Regina; Pagnoca, Erica Valessa Ramos Gomes; Campos, Karoline Rodrigues; Montanha, Janaína Olher Martins; Flores, Maricélia Navarro Pinheiro; Soares, Márcia Maria Costa Nunes; Binhardi, Fernanda Modesto Tolentino; Ferreira, Patrícia Marques; Yu, Ana Lucia Frugis; Carvalhanas, Telma Regina Marques Pinto; Abbud, Adriano; Bugno, Adriana; Sacchi, Claudio Tavares title: SARS-CoV-2 reinfection in a healthcare professional in inner Sao Paulo during the first wave of COVID-19 in Brazil date: 2021-08-20 journal: Diagn Microbiol Infect Dis DOI: 10.1016/j.diagmicrobio.2021.115516 sha: da38d6a117b7c3bb3be8aa3c43f260ee007f36fc doc_id: 755389 cord_uid: 6a7usdk6 Coronavirus Disease 2019 pandemic remains a threat to public health. We report 2 cases of Coronavirus Disease 2019 infection in the same healthcare professional in Brazil. Genomic analysis identified that primoinfection was caused by the endemic lineage B.1.1.33 while reinfection by the lineage B.1.1.44, a lineage with an additional V1176F mutation in S protein. Coronavirus Disease 2019 , caused by severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) emerged in China and rapidly evolved to a Public Health Emergency of International Concern (Harapan et al., 2020) . Until end of 2020, >75 millions of cases and >1,5 millions of deaths were reported worldwide (Dong et al., 2020) . Phylogenetic studies report different lineages of SARS-CoV-2 simultaneously circulating in a given region with particular specificities (Mercatelli and Giorgi, 2020) , mainly associated with neutral mutations not associated with enhanced transmissibility (van Dorp et al., 2020) . According to Global Initiative on Sharing All Influenza Data (GISAID) database, in Brazil, the most common concurrently circulating lineages are B.1.1.28, B.1.1.33 and P.1 and P.2 lineages, variants of concern derivatives of B.1.1.28. Although cases of reinfection are still rare (Larson et al., 2020 , Mulder et al., 2020 , Prado-Vivar et al., 2020 , Tillett et al., 2020 , weak or absent immunological response to SARS-CoV-2 after natural infection can occur (Wu et al., 2020) , which may contribute to reinfections as also observed with other seasonal coronavirus (Edridge et al., 2020) . The epidemiologic definition of reinfection considers the presence of distinct phylogenetic lineages in an interval of >90 days, and low CT in RT-PCR assays (Yahav et al., 2020) . Here, we report a confirmed episode of SARS-CoV-2 reinfection in a patient from Brazil. All biological samples suspected to be from cases of reinfection are sent to Central Instituto Adolfo Lutz Laboratory for further analysis and confirmation. For those samples, the RNA was reextracted using the automatic Extracta 32 (Loccus, Brazil) and the presence of E, N, RdRP and RNAseP genes were confirmed using the Allplex 2019-nCoV Assay (Korea, Seegene Inc.) on the QuantStudio 5 Real-Time PCR Systems (Applied Biosystems, USA). For genome sequencing, AmpliSeq TM SARS-CoV-2 (Thermo Fisher Scientific Inc., USA) was employed. Next, analysis were performed after quality control checking, assembly by IRMA (https://wonder. cdc.gov/amd/flu/irma/) and phylogenetics analysis in the GISAID database and BioNumerics 8.0 software (Applied Maths, Sint-Martens-Latem, Belgium). Sequences were deposited in the GISAID database under the accession IDs EPI_ISL_708529 and EPI_ISL_708530 and compared with reference WIV04-sequence (EPI_ISL_402124). Also, GISAID database was analyzed to compare the mutations present in S protein in all reinfection cases available (as of January 22, 2021). On December 10, 2020, the Central Laboratory received 2 biological samples from a female nursing assistant, aged 41 years old, living in Fernandopolis, Sao Paulo, Southeast Brazil. Patient did not report comorbidities except for a previous gastroplasty. The first sample was positive for SARS-CoV-2 on June 29, 2020 with CT values of 18 and 32 for E and RNAseP genes on qPCR, respectively. In her first episode, the patient reported headache, disseminated body pain, nonproductive cough, shortness of breath, ageusia, and anosmia. She did not require hospitalization or any other aggressive intervention. On November 21, 2020, after the patient presented again with symptoms of headache, cough, tiredness and myalgia, a second sample nasopharyngeal swabs were collected and positive for SARS-CoV-2 with CT values of 22 and 30 for E and RNAseP genes. In this second episode, the patient also reported diarrhea, appetite loss, dizziness, and chest pain. Temperature of 36.6°C and O 2 saturation of 98% were measured, and chest x-ray did not show abnormalities. Persistent fatigue and shortness of breath were reported 30 days after the diagnostic of the second SARS-CoV-2 infection, but with normal O 2 saturation. In comparison with the WIV04-sequence, mutations were identified in S, N and NSP proteins of both genomes, but reinfection case (lineage B.1.44) presented an additional V1176F mutation in S protein (Table 1 ). In addition, both sequences presented the R203K and G204R aminoacid change in the nucleocapsid (N) protein. On the other hand, only the EPI_ISL_708529 sequence presented the I292T and P383L in N protein, besides an I33T change in NS6 -Accessory protein 6 (NS6). Mutations found only in EPI_ISL_708530 included NSP2 V577F, NSP7 L71F, NSP12 P323L, and NSP16 R216N. Analyzing the publicly available sequences of infection and reinfection episodes, we found that the average value of mutations in S protein in reinfections episodes was numerically higher than those in the primoinfections (2.82 vs 1.09, respectively; P = 0.0974) ( Table 2) . Detection of reinfection in a patient from Brazil underscores the continuous threat of COVID-19 in a country suffering from uncontrolled epidemic about to be exacerbated by a second disease wave. Although clinical significance of COVID-19 reinfection remains to be totally elucidated, apprehensions clearly arise from the possibility that, in at least some individuals, the immunological response may be not enough to prevent a second infection. The reinfection case presented here is supported by the fact that clinical specimens were collected more than 90 days apart from the same symptomatic patient presenting positive results with low CT values for SARS-CoV-2. Moreover, the first episodes was caused by a common lineage circulating in Brazil, B.1.1.33, which is highly disseminated in the country, according to GISAID database (Rambaut et al., 2020) . B.1.1.44 is reported exclusively in this case in Brazil but another 616 entries (mainly from Europe) are deposited in the GISAID repository. Lineage B.1.1.44 was previously characterized as B.1.1.248 and B.1.1.28, another recurrent lineage circulating in Brazil since April, which originated the variants of concern P.1 (Gamma) and P.2, in increasing prevalence (Sabino et al., 2021) . A remarkable difference found in B.1.1.44 is an additional V1176F substitution besides the highly disseminated D614G amino acid substitution prevalent worldwide (Rahimi et al., 2020) ; increased number of mutations in S protein are also reported in other reinfection episodes (Table 2) . Mutation in the spike S2 domain V1176F is recognized to be the second more frequent in SARS-CoV-2 from South America, but its frequency is <3% in available viral genomes. Besides our epidemiological and genomic data, absence of patient serologies against SARS-CoV-2 cannot be ignored as potential limitation in this study. Finally, we report a reinfection case of COVID-19 in a patient from Brazil, demonstrated by genome sequencing, highlighting the potential of Brazilian lineages (and its derivatives) in causing reinfection. The impact of passive immunization on lineages circulation and effective protection against COVID-19 reinfection, however, deserves further evaluation. This study was funded by Coordenadoria de Controle de Doenças (CCD), Secretaria de Estado da Sa ude de São Paulo, Brazil and by the grants 2017/50333-7, 2018/21193-5, Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP). Sequences were deposited in the GISAID database under the accession IDs EPI_ISL_708529 and EPI_ISL_708530. This study was approved by the Local Ethics Committee (CAAE 139 37513020.7.0000.0059). The authors declare that there are no conflicts of interest. An interactive web-based dashboard to track COVID-19 in real time Seasonal coronavirus protective immunity is short-lasting Coronavirus disease 2019 (COVID-19): a literature review A case of early reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Geographic and genomic distribution of SARS-CoV-2 mutations Reinfection of severe acute respiratory syndrome coronavirus 2 in an immunocompromised patient: a case report COVID-19 Re-Infection by a phylogenetically distinct SARS-CoV-2 variant, first confirmed event in South America Genetics and genomics of SARS-CoV-2: a review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence Genomic evidence for reinfection with SARS-CoV-2: a case study Coronavirus disease 2019 (COVID-19) Re-infection by a phylogenetically distinct severe acute respiratory syndrome coronavirus 2 strain confirmed by whole genome sequencing No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2 Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications Definitions for COVID-19 reinfection, relapse and PCR re-positivity We are thankful to staff dedicated to COVID-19 diagnostic and control, namely those from Coordenação Geral de Laborat orios de Sa ude P ublica (CGLAB), Coordenadoria de Controle de Doenças (CCD) from Secretaria de Estado da Sa ude de São Paulo. Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.diagmicrobio.2021.115516.